Status:
COMPLETED
NAVITAS and ENVISION - Study to Characterize Select Objective Metrics & Clinical Outcomes in Chronic Pain Patients With Boston Scientific Neurostimulation Systems
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Pain, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to characterize the relationship between select objective metrics and clinical outcomes in chronic pain patients treated with Boston Scientific commercially approved neur...
Eligibility Criteria
Inclusion
- Key
- \- Is willing and able to comply with completing protocol required assessments and evaluations
- Key
Exclusion
- \- Has any pain-related diagnosis, medical/psychological condition or external factors that, in the investigator's medical judgment, might confound reporting of study outcomes (e.g. history of pelvic pain, anginal pain, chronic migraine, involved in litigation, workmen's compensation)
Key Trial Info
Start Date :
July 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 8 2024
Estimated Enrollment :
544 Patients enrolled
Trial Details
Trial ID
NCT03240588
Start Date
July 31 2017
End Date
March 8 2024
Last Update
May 8 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Hope Research Institute
Phoenix, Arizona, United States, 85018
2
Banner University Medical Center
Tucson, Arizona, United States, 85724
3
Coastal Research Institute
Carlsbad, California, United States, 92009
4
South Lake Pain Institute, Inc
Clermont, Florida, United States, 34711